肝脏原发性巨大恶性黑色素瘤1例

doi:10.3969/j.issn.1009-976X.2022.06.012

摘要/Abstract

摘要： 目的提高对肝原发性恶性黑色素瘤的认识并总结该疾病的诊治经验。方法回顾性分析本院收治的1例肝原发性恶性黑色素瘤患者的临床资料再结合国内外相关文献对该病的临床诊治经验加以总结。结果肝原发性恶性黑色素瘤临床表现缺乏特异性,术前诊断困难,主要依靠病理诊断,MRI对该病的诊断有很大的价值,治疗上以手术治疗为主,术后可应用放化疗及免疫治疗。结论肝原发性恶性黑色素瘤术前诊断需要有丰富的经验再结合MRI等影像学检查,治疗是以手术治疗为主结合放化疗、免疫治疗的综合治疗,对延长生命,提高生活质量具有重要意义。

关键词: 黑色素瘤, 恶性肿瘤, 肝脏, 原发性

Abstract: Objective To improve the understanding of primary malignant melanoma of the liver,and summarize the experience of diagnosis and treatment of this disease. Methods Clinical data of 1 patient with primary malignant melanoma of the liver was retrospectively analyzed and related literature was reviewed. Results Primary malignant melanoma of the liverwhich lack specific clinical features are uncommon and difficult to be diagnosed. The diagnosis is mainly based on pathology, MRI is of great value in the diagnosis of this disease. Surgical treatment is the main treatment,In combination with Rational application of chemoradiotherapy and immunotherapy. Conclusion The preoperative diagnosis of primary malignant melanoma of the liver requires rich experience combined with MRI and other imaging examinations. The treatment is mainly surgical treatment combined with radiotherapy, chemotherapy and immunotherapy, which is of great significance for prolonging life and improving the quality of life.

Key words: melanoma, malignant tumor, liver, primary

中图分类号:

R735.7

付建, 匡远黎. 肝脏原发性巨大恶性黑色素瘤1例[J]. 岭南现代临床外科, 2022, 22(06): 588-591.

FU Jian, KUANG Yuan-li. A case of primary malignant melanoma of liver[J]. Lingnan Modern Clinics In Surgery, 2022, 22(06): 588-591.

参考文献

[1] 张贵志, 翟薇, 刘宏, 等. 肝脏原发性恶性黑色素瘤一例[J]. 肿瘤研究与临床, 2013(02): 142-143.
[2] 巩丽, 赵建业. 肝脏原发性恶性黑色素瘤1例[J].临床与实验病理学杂志, 2008, 24(5): 638-639.
[3] Shan GD, Xu GQ, Chen LH, et al.Diffuse liver infiltration by Melanoma of unknown primary origin: one case report and literature review[J]. Intern Med, 2009, 48(24): 2093-2096.
[4] Nicole ML, Elisabeth D.Multipotentialityoftheneural crest[J]. CurrGene Der, 2003, 13: 529.
[5] 张禹,徐军. 肝脏原发性恶性黑色素瘤一例[J].临床放射学杂志, 2007, 27(7): 997.
[6] GabelliniC, TrisciuoglioD, Desideri M, et al. Functional activity of CXCL8 receptors, CXCR1 and CXCR2, on human malignant melanoma progression[J]. Eur J Cancer, 2009, 45: 2618-2627.
[7] 张晓晨, 葛丽萍, 田晖. 肝脏原发恶性黑色素瘤伴转移超声造影表现1例[J].临床超声医学杂志, 2022, 24(7): 666.
[8] 李之慧, 云晓静, 杨茂梧.原发性肝脏恶性黑色素瘤的诊治进展[J].中华消化病与影像杂志, 2016, 6(3): 133-136.
[9] 车亦蕾,张亚林.肝多发转移性黑色素瘤CT表现1例[J].中国现代医生杂志, 2019, 58(2): 148-150.
[10] Furuta M, Suto H, Nakamoto S, et al.MRI of malignant melanoma of liver[J]. RadiatNed, 1995, 13(3): 143-145.
[11] 谢辉, 安维民, 李勇. 肝恶性黑素瘤1例[J].现代医学杂志, 2012, 40(6): 734-735.
[12] 汪鑫, 张洪义. 肝恶性肿瘤精准外科手术治疗确定[J].中国临床医生杂志, 2022, 50(5): 516-520.
[13] Agarwala S S, Keilholz U, Gilles E, et al.LDH correlation with survival in advance Melanoma from two large, randomised trials(Oblimersen GM301 and EORTC 18951)[J].Eur J Cancer, 2009, 45(10): 1807-1814.
[14] 杨华员, 郑勤. 恶性黑色素瘤的免疫治疗现状与进展[J].现代肿瘤医学杂志, 2011, 19(11): 2341-2345.
[15] Patsoukis N, Brown J, Petkova V, et al. Selective effects of PD-1 on Akt and Ras pathways regulate molecular components of the cell cycle and inhibit T cell proliferation[J]. Sci Signal, 2012, 5(230): ra46.
[16] 陈心怡, 陈昌志, 曾凡. 肝原发性恶性黑素瘤1例[J].肝胆外科杂志, 2009, 17(6): 478-479.